Characterization of isolated tau-reactive antibodies from the IVIG product, plasma of patients with Alzheimer's disease and cognitively normal individuals

被引:11
作者
Krestova, Michala [1 ,2 ]
Hromadkova, Lenka [1 ,3 ,4 ]
Bilkova, Zuzana [4 ]
Bartos, Ales [1 ,2 ]
Ricny, Jan [1 ]
机构
[1] Natl Inst Mental Hlth, Klecany, Czech Republic
[2] Charles Univ Prague, Fac Med 3, Prague, Czech Republic
[3] Charles Univ Prague, Fac Sci, Prague, Czech Republic
[4] Univ Pardubice, Dept Biol & Biochem Sci, Pardubice, Czech Republic
关键词
Alzheimer's disease; Brain homogenates; Plasma antibodies; Reactivity profile; Tau protein; INTRAVENOUS IMMUNOGLOBULIN PRODUCTS; NATURALLY-OCCURRING AUTOANTIBODIES; NEUROFIBRILLARY TANGLES; NEURONAL-ACTIVITY; PATHOLOGICAL TAU; ENDOGENOUS TAU; AMYLOID-BETA; A-BETA; IMMUNOTHERAPY; PROTEIN;
D O I
10.1016/j.jneuroim.2017.09.011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The presence of natural tau-reactive antibodies was reported in human blood. In this study, we isolated and characterized natural tau-reactive antibodies occurring in IVIG product Flebogamma, plasma of patients with Alzheimer's disease (AD) and older cognitively normal persons (controls). Using blotting immunoassays and ELISA, we showed reactivity of antibodies obtained from IVIG and controls against a recombinant fragment of tau (155-421 aa) and aggregates present in brains of AD patients. In contrast, antibodies isolated from plasma of AD patients reacted mainly with the recombinant full-length tau form and tau monomeric forms in brain tissue.
引用
收藏
页码:16 / 24
页数:9
相关论文
共 50 条
[31]   Characterization of microtubule-associated protein tau isoforms and Alzheimer's disease-like pathology in normal sheep (Ovis aries): relevance to their potential as a model of Alzheimer's disease [J].
Davies, Emma S. ;
Morphew, Russell M. ;
Cutress, David ;
Morton, A. Jennifer ;
McBride, Sebastian .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (11)
[32]   Resting State Functional Connectivity Signature Differentiates Cognitively Normal from Individuals Who Convert to Symptomatic Alzheimer's Disease [J].
Wisch, Julie K. ;
Roe, Catherine M. ;
Babulal, Ganesh M. ;
Schindler, Suzanne E. ;
Fagan, Anne M. ;
Benzinger, Tammie L. ;
Morris, John C. ;
Ances, Beau M. .
JOURNAL OF ALZHEIMERS DISEASE, 2020, 74 (04) :1085-1095
[33]   Cerebrospinal fluid tau and ptau181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease [J].
Fagan, Anne M. ;
Mintun, Mark A. ;
Shah, Aarti R. ;
Aldea, Patricia ;
Roe, Catherine M. ;
Mach, Robert H. ;
Marcus, Daniel ;
Morris, John C. ;
Holtzman, David M. .
EMBO MOLECULAR MEDICINE, 2009, 1 (8-9) :371-380
[34]   BACE1 and Other Alzheimer's-Related Biomarkers in Cerebrospinal Fluid and Plasma Distinguish Alzheimer's Disease Patients from Cognitively-Impaired Neurosyphilis Patients [J].
Zhang, Min ;
Zhong, Xiaomei ;
Shi, Haishan ;
Vanmechelen, Eugeen ;
De Vos, Ann ;
Liu, Sen ;
Chen, Ben ;
Mai, Naikeng ;
Peng, Qi ;
Chen, Xinru ;
Wu, Zhangying ;
Hou, Le ;
Zhou, Huarong ;
Ouyang, Cong ;
Zhang, Weiru ;
Liang, Wanyuan ;
Dai, Chunying ;
Ning, Yuping .
JOURNAL OF ALZHEIMERS DISEASE, 2020, 77 (01) :313-322
[35]   Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer's disease [J].
Silajdzic, Edina ;
Bjorkqvist, Maria ;
Hansson, Oskar .
BMC NEUROLOGY, 2015, 15
[36]   Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease [J].
Edina Silajdžić ;
Maria Björkqvist ;
Oskar Hansson .
BMC Neurology, 15
[37]   Assessing diagnostic performance of plasma biomarkers in Alzheimer's disease versus cognitively unimpaired individuals: P-tau217 emerges as the optimal marker in Chinese cohorts [J].
Wang, Shinan ;
Liu, Dequan ;
Li, Haiyan ;
Jia, Xiaodong ;
Zhou, Hailan ;
Yu, Wenying ;
Li, Tong ;
Pan, Liping ;
Chen, Baorong ;
Wang, Yujia ;
Zhan, Nan ;
Song, Yijun ;
Yan, Keqiang .
FRONTIERS IN AGING NEUROSCIENCE, 2025, 17
[38]   Association of Rapidly Elevated Plasma Tau Protein With Cognitive Decline in Patients With Amnestic Mild Cognitive Impairment and Alzheimer's Disease [J].
Chu, Che-Sheng ;
Lin, Yu-Kai ;
Tsai, Chia-Lin ;
Sung, Yueh-Feng ;
Lin, Guan-Yu ;
Ko, Chien-An ;
Liu, Yi ;
Liang, Chih-Sung ;
Yang, Fu-Chi .
PSYCHIATRY INVESTIGATION, 2025, 22 (02) :130-139
[39]   Obesity and White Matter Neuroinflammation Related Edema in Alzheimer's Disease Dementia Biomarker Negative Cognitively Normal Individuals [J].
Ly, Maria ;
Raji, Cyrus A. ;
Yu, Gary Z. ;
Wang, Qing ;
Wang, Yong ;
Schindler, Suzanne E. ;
An, Hongyu ;
Samara, Amjad ;
Eisenstein, Sarah A. ;
Hershey, Tamara ;
Smith, Gordon ;
Klein, Samuel ;
Liu, Jingxia ;
Xiong, Chengjie ;
Ances, Beau M. ;
Morris, John C. ;
Benzinger, Tammie L. S. .
JOURNAL OF ALZHEIMERS DISEASE, 2021, 79 (04) :1801-1811
[40]   Test-retest repeatability of [18F]Flortaucipir PET in Alzheimer's disease and cognitively normal individuals [J].
Timmers, Tessa ;
Ossenkoppele, Rik ;
Visser, Denise ;
Tuncel, Hayel ;
Wolters, Emma E. ;
Verfaillie, Sander C. J. ;
van der Flier, Wiesje M. ;
Boellaard, Ronald ;
Golla, Sandeep S., V ;
van Berckel, Bart N. M. .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2020, 40 (12) :2464-2474